BAM
ONC

Belpointe Asset Management’s BeOne Medicines Ltd ONC Stock Holding History

Belpointe Asset Management’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-25
Closed -$5.39K – 3495
2023
Q1 		$5.39K Hold
25
– – ﹤0.01% 2988
2022
Q4 		$5.5K Buy
+25
New +$4.58K ﹤0.01% 2898
2018
Q4 		– Sell
-15,998
Closed -$2.75M – 649
2018
Q3 		$2.75M Buy
15,998
+12,138
+314% +$2.04M 0.44% 35
2018
Q2 		$593K Buy
3,860
+81
+2% +$14.4K 0.17% 126
2018
Q1 		$635K Sell
3,779
-12,129
-76% -$1.64M 0.19% 115
2017
Q4 		$1.55M Buy
15,908
+40
+0.3% +$3.66K 0.34% 60
2017
Q3 		$1.64M Buy
+15,868
New +$1.18M 0.38% 52

Other funds holding ONC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $29.7B AUM 13.98% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CII
Capital International Inc Los Angeles, California $13B AUM 31.88% 1-Year Est. Return